Edwards Lifesciences Corporation Defined Benefit Plan, Interest Cost
Edwards Lifesciences Corporation (EW) reported Defined Benefit Plan, Interest Cost of $1.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanInterestCost · last filed 2026-02-25
- Edwards Lifesciences Corporation defined benefit plan, interest cost for fiscal 2025 was $1.70M, a 10.53% decline from fiscal 2024.
- Edwards Lifesciences Corporation defined benefit plan, interest cost for fiscal 2024 was $1.90M, a 17.39% decline from fiscal 2023.
- Edwards Lifesciences Corporation defined benefit plan, interest cost for fiscal 2023 was $2.30M, a 360.00% increase from fiscal 2022.
- Edwards Lifesciences Corporation defined benefit plan, interest cost for fiscal 2022 was $500.00K.
| Period end | Defined Benefit Plan, Interest Cost 12 month |
|---|---|
| 2025-12-31 | $1.70M 10-K · filed 2026-02-25 |
| 2024-12-31 | $1.90M 10-K · filed 2026-02-25 |
| 2023-12-31 | $2.30M 10-K · filed 2026-02-25 |
| 2022-12-31 | $500.00K 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |